Yemisi Bokinni, a freelance journalist in London, reports on the economic struggles facing Nigeria due to the departure of major drug companies. This has led to a 1100% increase in antibiotic costs and other healthcare prices in the country. The escalating drug prices reflect a larger issue with Nigeria’s economy, with inflation reaching a 27-year high of 28.92%. Major pharmaceutical companies like GlaxoSmithKline and Sanofi have announced their withdrawal from the country, shifting to a third-party distribution model. This dilemma is seen in other developing countries where essential drugs are significantly more expensive than in developed nations due to various factors.
Source link